Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	39357
Country	Türkiye

Received	2018-04-20 11:45
Peer-Review Started	2018-04-21 12:07
To Make the First Decision	2018-06-13 00:09
Return for Revision	2018-06-13 06:29
Revised	2018-09-08 04:59
Second Decision	2018-10-23 00:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2018-10-23 16:36
Articles in Press	2018-10-23 16:36
Publication Fee Transferred
Edit the Manuscript by Language Editor	2019-01-04 09:36
Typeset the Manuscript	2019-02-15 01:23
Publish the Manuscript Online	2019-02-15 09:46

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumors group
Manuscript Source	Unsolicited Manuscript
All Author List	Ömer Komaç, Göksel Bengi, Özgül Sağol and Mesut Akarsu
Funding Agency and Grant Number
Corresponding Author	Göksel Bengi, MD, Assistant Professor, Department of Gastroenterology, Dokuz Eylul University Faculty of Medicine, Inciraltı, Izmir 35000, Türkiye. goksel.bengi@deu.edu.tr
Key Words	Gastroenteropancreatic neuroendocrine tumors; C-reactive protein; Prognostic factor; Neuroendocrine tumors; Gastrointestinal system
Core Tip	Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) constitute a heterogeneous group of tumors with variable clinical presentations, different growth rates and unpredictable prognoses. In our study, we aimed to identify the independent prognostic markers for the patients in the whole GEP-NET group. As a result, it was observed that one of the biochemical parameters, C-reactive protein (CRP) affected the course of the progression in the worst way (particularly if it is > 20 mg/dL). With the need for larger scale and prospective studies, it was suggested that CRP level might be a poor prognostic factor for the entire GEP-NET group.
Publish Date	2019-02-15 09:46
Citation	Komaç Ö, Bengi G, Sağol Ö, Akarsu M. C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumors group. World J Gastrointest Oncol 2019; 11(2): 139-152
URL	https://www.wjgnet.com/1948-5204/full/v11/i2/139.htm
DOI	https://dx.doi.org/10.4251/wjgo.v11.i2.139

Full Article (PDF)	WJGO-11-139.pdf
Full Article (Word)	WJGO-11-139.docx
Manuscript File	39357-Review.docx
Answering Reviewers	39357-Answering reviewers.pdf
Audio Core Tip	39357-Audio core tip.mp3
Biostatistics Review Certificate	39357-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	39357-Conflict-of-interest statement.pdf
Copyright License Agreement	39357-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	39357-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	39357-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	39357-Language certificate.pdf
Peer-review Report	39357-Peer-review(s).pdf
Scientific Misconduct Check	39357-Scientific misconduct check.pdf
Scientific Editor Work List	39357-Scientific editor work list.pdf